✦ LIBER ✦

Cost-Effectiveness of Duloxetine Versus Routine Treatment for U.S. Patients With Diabetic Peripheral Neuropathic Pain

✍ Scribed by Eric Q. Wu; Howard G. Birnbaum; Milena N. Mareva; T. Kim Le; Rebecca L. Robinson; Amy Rosen; Steve Gelwicks

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative safety of duloxetine versus

✍ G. Irving; R. Tanenberg; D. Hann; J. Raskin; S. Malcolm; R. Risser 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Evaluating the maintenance of effect of

✍ Vladimir Skljarevski; Durisala Desaiah; Qi Zhang; Amy S. Chappell; Michael J. De 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

Predictors of Duloxetine versus Other Tr

✍ Yingnan Zhao; Jinan Liu; Yang Zhao; Tina Thethi; Vivian Fonseca; Lizheng Shi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

PDB19 TIME TO OPIOID USE AND HEALTH CARE

✍ Y Zhao; SY Chen; L Boulanger; K Fraser; N Wu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Opioid use among patients with diabetic

✍ Y. Zhao; L. Boulanger; K. Fraser; N. Wu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Safety and tolerability of duloxetine tr

✍ Joachim F. Wernicke; Apurva Prakash; Daniel K. Kajdasz; John Houston 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 309 KB